vs
Side-by-side financial comparison of Relay Therapeutics, Inc. (RLAY) and TRANSACT TECHNOLOGIES INC (TACT). Click either name above to swap in a different company.
TRANSACT TECHNOLOGIES INC is the larger business by last-quarter revenue ($11.5M vs $7.0M, roughly 1.6× Relay Therapeutics, Inc.). TRANSACT TECHNOLOGIES INC produced more free cash flow last quarter ($589.0K vs $-235.9M).
Relay Therapeutics is a clinical-stage biotechnology company focused on developing precision oncology therapies. It leverages advanced computational modeling of protein dynamics, paired with cutting-edge experimental biology, to design targeted medicines for previously intractable cancer types, serving global oncology care markets and patient populations.
Roper Technologies, Inc. is a holding company that owns companies in the technology sector.
RLAY vs TACT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $7.0M | $11.5M |
| Net Profit | — | — |
| Gross Margin | — | 47.6% |
| Operating Margin | — | -10.1% |
| Net Margin | — | — |
| Revenue YoY | — | 11.9% |
| Net Profit YoY | — | — |
| EPS (diluted) | — | $-0.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $7.0M | $11.5M | ||
| Q3 25 | $0 | $13.2M | ||
| Q2 25 | — | $13.8M | ||
| Q1 25 | $7.7M | $13.1M | ||
| Q4 24 | $0 | $10.2M | ||
| Q3 24 | $0 | $10.9M | ||
| Q2 24 | $0 | $11.6M | ||
| Q1 24 | $10.0M | $10.7M |
| Q4 25 | — | — | ||
| Q3 25 | $-74.1M | $15.0K | ||
| Q2 25 | — | $-143.0K | ||
| Q1 25 | $-77.1M | $19.0K | ||
| Q4 24 | — | — | ||
| Q3 24 | $-88.1M | $-551.0K | ||
| Q2 24 | $-92.2M | $-319.0K | ||
| Q1 24 | $-81.4M | $-1.0M |
| Q4 25 | — | 47.6% | ||
| Q3 25 | — | 49.8% | ||
| Q2 25 | — | 48.2% | ||
| Q1 25 | — | 48.7% | ||
| Q4 24 | — | 44.2% | ||
| Q3 24 | — | 48.1% | ||
| Q2 24 | — | 52.7% | ||
| Q1 24 | — | 52.6% |
| Q4 25 | — | -10.1% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | -1.9% | ||
| Q1 25 | -1105.2% | -0.1% | ||
| Q4 24 | — | -10.3% | ||
| Q3 24 | — | -7.7% | ||
| Q2 24 | — | -3.8% | ||
| Q1 24 | -903.0% | -12.2% |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | -1.0% | ||
| Q1 25 | -1003.6% | 0.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -5.1% | ||
| Q2 24 | — | -2.8% | ||
| Q1 24 | -813.3% | -9.7% |
| Q4 25 | — | $-0.11 | ||
| Q3 25 | $-0.43 | $0.00 | ||
| Q2 25 | — | $-0.01 | ||
| Q1 25 | $-0.46 | $0.00 | ||
| Q4 24 | — | $-0.80 | ||
| Q3 24 | $-0.63 | $-0.06 | ||
| Q2 24 | $-0.69 | $-0.03 | ||
| Q1 24 | $-0.62 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $84.0M | $20.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $567.1M | $31.1M |
| Total Assets | $621.3M | $44.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $84.0M | $20.4M | ||
| Q3 25 | $91.6M | $20.0M | ||
| Q2 25 | — | $17.7M | ||
| Q1 25 | $93.5M | $14.2M | ||
| Q4 24 | $124.3M | $14.4M | ||
| Q3 24 | $152.4M | $11.3M | ||
| Q2 24 | $134.1M | $11.1M | ||
| Q1 24 | $152.9M | $10.6M |
| Q4 25 | $567.1M | $31.1M | ||
| Q3 25 | $607.7M | $31.8M | ||
| Q2 25 | — | $31.3M | ||
| Q1 25 | $721.1M | $30.9M | ||
| Q4 24 | $777.8M | $30.6M | ||
| Q3 24 | $838.9M | $38.4M | ||
| Q2 24 | $681.7M | $38.5M | ||
| Q1 24 | $745.8M | $38.6M |
| Q4 25 | $621.3M | $44.8M | ||
| Q3 25 | $670.0M | $45.0M | ||
| Q2 25 | — | $44.5M | ||
| Q1 25 | $799.4M | $44.2M | ||
| Q4 24 | $871.3M | $44.0M | ||
| Q3 24 | $930.1M | $50.5M | ||
| Q2 24 | $772.5M | $50.4M | ||
| Q1 24 | $841.4M | $51.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-235.5M | $609.0K |
| Free Cash FlowOCF − Capex | $-235.9M | $589.0K |
| FCF MarginFCF / Revenue | -3370.0% | 5.1% |
| Capex IntensityCapex / Revenue | 5.9% | 0.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-622.7M | $7.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-235.5M | $609.0K | ||
| Q3 25 | $-62.1M | $3.6M | ||
| Q2 25 | — | $3.6M | ||
| Q1 25 | $-73.2M | $-161.0K | ||
| Q4 24 | $-249.1M | $2.4M | ||
| Q3 24 | $-75.1M | $327.0K | ||
| Q2 24 | $-65.8M | $636.0K | ||
| Q1 24 | $-50.3M | $-1.5M |
| Q4 25 | $-235.9M | $589.0K | ||
| Q3 25 | $-62.1M | $3.6M | ||
| Q2 25 | — | $3.6M | ||
| Q1 25 | $-73.6M | $-171.0K | ||
| Q4 24 | $-251.1M | $2.4M | ||
| Q3 24 | $-75.3M | $259.0K | ||
| Q2 24 | $-65.8M | $499.0K | ||
| Q1 24 | $-52.1M | $-1.6M |
| Q4 25 | -3370.0% | 5.1% | ||
| Q3 25 | — | 27.1% | ||
| Q2 25 | — | 25.9% | ||
| Q1 25 | -958.4% | -1.3% | ||
| Q4 24 | — | 23.2% | ||
| Q3 24 | — | 2.4% | ||
| Q2 24 | — | 4.3% | ||
| Q1 24 | -520.7% | -14.9% |
| Q4 25 | 5.9% | 0.2% | ||
| Q3 25 | — | 0.5% | ||
| Q2 25 | — | 0.1% | ||
| Q1 25 | 5.0% | 0.1% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | 0.6% | ||
| Q2 24 | — | 1.2% | ||
| Q1 24 | 17.8% | 1.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | 242.00× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -8.47× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
